Krystal Biotech (KRYS) PT Raised to $396 at BofA Securities

July 13, 2026 11:05 AM

BofA Securities analyst Alec Stranahan raised the price target on Krystal Biotech (NASDAQ: KRYS) to $396.00 (from $364.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found